**Sir Chris Hoy Urges Earlier Prostate Cancer Screening Following Personal Diagnosis**

In an emotive public plea, Sir Chris Hoy has called for urgent changes to the way prostate cancer is tested and diagnosed across the UK. The six-time Olympic cycling champion, who was diagnosed with stage four prostate cancer in 2023 at just 47 years old, has become an increasingly vocal advocate for lowering the age of routine screening and increasing awareness among men of all ages.
Hoy, now 49, first revealed his diagnosis to the public last year, sharing that the cancer had already progressed to his bones by the time it was discovered. His experience, which falls outside the NHS’s typical age bracket for prostate cancer screening, has prompted him to campaign for wider, earlier testing to prevent others facing a similar prognosis.

Speaking about his journey since going public, Hoy described the vital role his personal support network has played. “Across all the challenges in my career and life, being open about my cancer diagnosis was one of the toughest,” he explained. “The network of encouragement from my family, friends, and countless members of the public has truly lifted me. It’s offered a new sense of purpose—I’m using my platform to shine a light on prostate cancer, which is unfortunately the most common cancer affecting men in the UK.”
At present, NHS guidelines advise that men over 50—especially those with either a family history of the disease or of Black heritage—should speak to their GP about prostate cancer risks, with routine screening rarely offered to younger men. Hoy’s story, however, highlights how this approach may leave a significant group of men undiagnosed until their illness is advanced.

Emphasising the urgency of earlier detection, Hoy recounted, “When I was diagnosed it was already stage four. Given the nature of prostate cancer, it’s very likely it started developing when I was 45, if not earlier. The tragic reality is that the sooner the condition is caught, the more effective the treatment can be.” He added that he is determined to see policy changed to widen the window for early diagnosis, sparing more men the ordeal he faces.
Symptoms of prostate cancer can include increased frequency of urination, difficulty passing urine, and a persistent feeling that the bladder hasn’t been fully emptied. The NHS currently relies on tools such as prostate-specific antigen (PSA) blood tests, physical examinations, MRI scans and biopsies to assess and diagnose suspected cases.
Hoy’s campaign dovetails with those of leading charities such as Prostate Cancer UK, who are now lobbying for GPs to discuss the disease proactively with men at higher risk, even from the age of 45. The charity is seeking a complete overhaul of NHS protocols, echoing Hoy’s view that prevention and early detection could have a transformative effect on outcomes.
Nearly one in eight men in the UK will develop prostate cancer at some stage in their lives—a stark statistic that underscores the critical importance of Hoy’s message. If not caught early, the cancer can metastasise, making it more difficult to treat and reducing survival rates significantly.
Reflecting on his hopes for the future, Hoy explained: “We should be ensuring high-risk men, such as those with family histories or Black men, are engaged by their GP at a much earlier stage. A straightforward PSA test could save lives if performed before symptoms begin. My story has been shared in the hope of sparking more widespread awareness, but this issue goes beyond personal responsibility. The system itself needs to evolve.”
With his openness and continued advocacy, Sir Chris Hoy is sparking renewed debate and action over one of the UK’s most prevalent male cancers. His resilience in facing terminal illness while pushing for widespread change serves both as an inspiration and a call to arms for healthcare professionals, policymakers, and the public alike.
As campaigners and charities rally behind his vision, it remains to be seen whether NHS policies will shift towards the kind of early intervention and outreach that could change the course of countless lives in years to come.